Lipidzyme
Natural health product licensed in Canada
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80123072
- Status
- Active licence
- Licence date
- 7 February 2023
- Revision date
- 9 February 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 1,250 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 125 mg | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 70 mg | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 17,500 FCC HUT | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 62.5 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 5,000 FCC DU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 32.5 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier | 650 FCC CU | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 25 mg | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 15 FCC GU | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | minimum: 2 days ; maximum: 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzyme. Digestive Aid. Helps digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80123072
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.